These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1359825)
1. Effects of orally administered beta-adrenergic blockers and calcium-channel blockers on the intraocular pressure of patients with treated hypertension. Suzuki R; Hanada M; Fujii H; Kurimoto S Ann Ophthalmol; 1992 Jun; 24(6):220-3. PubMed ID: 1359825 [TBL] [Abstract][Full Text] [Related]
2. Treating hypertension. Are the right drugs given to the right patients? Beaulieu MD; Dufresne L; LeBlanc D Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833 [TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290 [TBL] [Abstract][Full Text] [Related]
4. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension]. Román O; Cuevas G; Bunout D Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766 [TBL] [Abstract][Full Text] [Related]
5. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091 [TBL] [Abstract][Full Text] [Related]
6. Current status of antihypertensive prescription and associated blood pressure control in Japan. Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149 [TBL] [Abstract][Full Text] [Related]
7. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2. Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721 [TBL] [Abstract][Full Text] [Related]
9. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs. de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925 [TBL] [Abstract][Full Text] [Related]
10. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure. Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011 [TBL] [Abstract][Full Text] [Related]
12. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients. Zheng S; Nath V; Coyne DW Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014 [TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy]. Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():103-8. PubMed ID: 2575367 [TBL] [Abstract][Full Text] [Related]
14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age]. Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of the effectiveness of combined use of local and general hypotensive agents in patients with glaucoma and hypertension]. Zakharova IA; Makhmutov VIu; Pristavka VA; Kul'kova SV Vestn Oftalmol; 2002; 118(1):44-6. PubMed ID: 11898362 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study]. Trinquand C; Romanet JP; Nordmann JP; Allaire C; J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585 [TBL] [Abstract][Full Text] [Related]
18. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). Frishman WH; Hainer JW; Sugg J; Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575 [TBL] [Abstract][Full Text] [Related]
19. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study. Greenfield DS; Liebmann JM; Ritch R; Krupin T; Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318 [TBL] [Abstract][Full Text] [Related]
20. [Recent intervention studies with antihypertensive drugs and their influence on guidelines]. Rahn KH Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]